Highest-materiality recent filing
LanzaTech JV Beijing Shougang completes HK IPO at ~$750M valuation, LanzaTech stake diluted to 8.38%
JV Beijing Shougang LanzaTech priced 40M H Shares at ~US$1.86 each on Hong Kong Stock Exchange, gross proceeds ~$75M.
Gross proceeds of $20.0M from sale of 2,000,000 shares at $10.00 per share; closing expected May 18, 2026.
LanzaTech Q1 net loss narrows to $14.7M; capital raises alleviate going concern doubt
Q1 net loss of $14.7M vs $19.2M YoY; Adj. EBITDA loss narrowed to $7.9M from $30.5M.
LanzaTech dismisses Deloitte, names BDO as auditor; prior reports flagged going-concern doubt
Dismissed Deloitte & Touche and engaged BDO USA as independent auditor for FY2026, effective April 10, 2026.
LanzaTech FY2025 net loss narrows to $49M; opex down 21% YoY
Net loss improved to $49.0M from $137.7M in 2024; Adjusted EBITDA loss narrowed to $71.3M from $88.2M.
LanzaTech raises $20M in PIPE; preferred stock converts to common shares
Raised $20M from PIPE: 4,000,000 shares at $5.00 each plus 510,968 bonus shares to institutional investors.
LanzaTech Q3 revenue $9.3M, net income $2.9M; LanzaJet ethanol-to-jet plant operational
Revenue $9.3M vs $9.9M YoY; net income $2.9M vs net loss $57.4M.
Eliminates SPE Investment Condition; LanzaJet issues second tranche of 15M shares promptly, third by Dec 31, 2025 or milestone.
Extended deadline for common stock financing to Oct 15, 2025; target $35M-$60M at $5/share post reverse split.
LanzaTech Q2 revenue falls 48% YoY to $9.1M; net loss widens to $32.5M
Revenue of $9.1M in Q2 2025, down from $17.4M in Q2 2024; six-month revenue $18.6M vs $27.6M.
Reverse stock split effective Aug 18, 2025; every 100 shares become 1 to meet Nasdaq minimum bid price.
LanzaTech shareholders approve 100-for-1 reverse split and authorize 2.58B shares
Authorized common shares increased from 600M to 2.58B (Proposal 4 approved 178.9M for, 36.5M against).
LanzaTech amends loan with Brookfield: extends maturity to Dec 2029, adjusts interest terms
Loan principal plus accrued interest outstanding as of July 10, 2025: $49,051,703.
LanzaTech extends BGTF loan to Dec 2029 (8%/12% interest); appoints CAO
Loan maturity extended from Oct 2027 to Dec 2029; interest accrues at 8% through Dec 2028 then 12% through Dec 2029.
LanzaTech names Sushmita Koyanagi CFO; GC resigns; board member retires; $1M cost savings
CFO Justin Pugh steps down June 2; CAO Sushmita Koyanagi appointed permanent CFO effective same date.
LanzaTech Q1 revenue $9.5M, net loss $19.2M; going concern doubt remains despite $40M equity
Total revenue $9.5M, down from $10.2M YoY; CarbonSmart revenue growth offset biorefining and JDA declines.
LanzaTech issues $40M Series A preferred stock; converts $40.2M notes; plans workforce reduction
Issued 20M Series A Convertible Senior Preferred shares for $40M to a large existing investor; $40.2M Convertible Notes due 2029 converted into 34M common shares.
LanzaTech FY2024 revenue $49.6M (down 21%), net loss $137.7M; going concern doubt
Q4 revenue $12.0M vs $20.5M in Q4 2023; full-year revenue $49.6M vs $62.6M.
LanzaTech delays FY2024 earnings, hires Rothschild for strategic options review
Board appointed Jill Frizzley as Class III director; she will serve on Strategic Committee; monthly fee $40,000 plus $7,500 per diem.
LanzaTech receives Nasdaq bid price non-compliance notice; 180 days to regain $1.00 minimum
Nasdaq notified LanzaTech (LNZA) on March 13, 2025 that its common stock closing bid price has been below $1.00 for 30 consecutive business days.
LanzaTech targets ~$30M annual cash cost savings, plans 10-15% workforce reduction
Targeting ~$30M in annual cash operating expense reductions through cost structure right-sizing.
LanzaTech converts $60M SAFE into loan with Brookfield; $12.5M due Feb 21, 2025
Loan of $60,030,750 (initial $50M plus 8% compounded interest from Oct 2022) replaces the SAFE; $12.5M principal due Feb 21, 2025.
LanzaTech to spin out LanzaX synthetic biology unit as JV with Tharsis; appoints interim CFO
CFO Geoff Trukenbrod resigned effective Jan 21, 2025; Justin Pugh (FTI) appointed interim CFO.
LanzaTech and Technip Energies secure up to $200M DOE commitment for Project SECURE
DOE commits up to $200M; Phase 1 FEED study budget $39.4M, with $19.7M from DOE.
LanzaTech Q3 revenue $9.9M, net loss $57.4M; expands model beyond licensing
Revenue $9.9M, down 49% YoY from $19.6M; net loss $57.4M vs $25.3M loss.
LanzaTech and Eramet announce plans for first-of-a-kind integrated CCUS project in Norway
Project at Herøya Industrial Park in Porsgrunn, Norway will produce ethanol from furnace gas supplied by Eramet's manganese smelter.
LanzaTech terminates Forward Purchase Agreement, pays $10M, retires 2.9M shares
On Oct 4, 2024, ACM triggered VWAP acceleration of FPA; LanzaTech settled in cash for $7.5M maturity + $2.5M share consideration.
LanzaTech: maximum $150M financing, forward purchase agreement triggered with $10M payout
ACM delivered VWAP Trigger Event notice Oct 4, accelerating maturity on 2,926,514 shares.
LanzaTech announces LanzaTech Nutritional Protein (LNP) as primary product using new microbe in gas fermentation.
LanzaTech Q2 revenue $17.4M (+35% YoY), reaffirms FY outlook, closes $40M capital raise
Q2 2024 revenue $17.4M, up 35% YoY; gross profit $11.9M (68% margin).
LanzaTech secures up to $150M convertible note financing; $40.15M issued initially
Convertible note purchase agreement for up to $150M; initial closing of $40.15M on August 6, 2024.
LanzaTech sues Vellar over disputed acceleration of Forward Purchase Agreement; faces $10M+ claims
On July 24, 2024, LanzaTech filed suit against Vellar in NY Supreme Court for breach of Forward Purchase Agreement and related claims.
LanzaTech increases LanzaJet ownership to ~36%, with future tranches to ~53% over 12-18 months
Ownership in LanzaJet rose to ~36% from ~23% after receiving first of three equity tranches on June 18, 2024.
LanzaTech Q1 revenue $10.2M, net loss narrows to $25.5M, reiterates FY 2024 guidance
Q1 total revenue $10.2M, up 6% YoY; gross margin 34% up from 19%.
On June 16, 2025, Michael Heraty, the Chief Accounting Officer of LanzaTech Global, Inc. (the “Company”), submitted his resignation, effective as of June 26, 2025.
Sushmita Koyanagi, the Company’s Chief Financial Officer, is expected to assume the responsibilities of principal accounting officer
on June 2, 2025, the Board of Directors of the Company appointed Michael Heraty, Vice President – Internal Audit & SOX Compliance to serve as Chief Accounting Officer of the Company following Sushmita Koyanagi’s promotion to Chief Financial Officer.
on June 2, 2025, the Board of Directors of the Company appointed Michael Heraty, Vice President – Internal Audit & SOX Compliance to serve as Chief Accounting Officer of the Company following Sushmita Koyanagi’s promotion to Chief Financial Officer.
Sushmita Koyanagi, the Company's then-current Chief Accounting Officer, would take on the position of Chief Financial Officer.
Justin Pugh would step down from his role as the Company's interim Chief Financial Officer
Sushmita Koyanagi, the Company’s current Chief Accounting Officer, would take on the position of Chief Financial Officer.
Amanda Koenig Fuisz, Deputy General Counsel, will serve as interim General Counsel effective as of such date.
On May 22, 2025, Joseph Blasko, General Counsel and Corporate Secretary, notified the Company of his decision to resign, effective June 13, 2025, in order to pursue another professional opportunity.
effective June 2, 2025, Justin Pugh would step down from his role as the Company’s interim Chief Financial Officer
On May 23, 2025, Gary Rieschel notified the Company of his decision to not stand for re-election as a member of the Board.
On March 20, 2025, the Board of Directors (the “Board”) of LanzaTech Global, Inc. (the “Company”) increased the size of the Board from eight (8) directors to nine (9) directors and appointed Jill Frizzley to fill the vacancy created by the increase in the number of directors.
Max materiality 0.90 · Median 0.65 · Most common event other_material